Vector Sciences uses AI as a tool to identify the optimal antigens or epitopes to pair with its adenovirus vector to induce the most effective immune response.

Kris Brown states that the Biden administration has made developing a universal influenza vaccine a major policy focus.

Vector Sciences is currently focusing its Riovax platform on developing an influenza vaccine due to the large market size and unmet need.